Business
Jaguar Health Announces Time Change for March 27th Investor Webcast to 8:00 AM EDT
Click here to register for webcastCompany plans to file its Annual Report on March 24, 2023 on Form 10-K for the fiscal year ended December 31, 2022SAN
About this update from Jaguar Health, Inc.
[{"type":"text","content":"Click here to register for webcastCompany plans to file its Annual Report on March 24, 2023 on Form 10-K for the fiscal year ended December 31, 2022SAN FRANCISCO, CA / ACCESSWIRE / March 24, 2023 / Jaguar Health, Inc. (NASDAQ:JAGX) today announced that the company investor webcast scheduled for Monday, March 27, 2023 to review fourth-quarter 2022 financials and provide corporate updates will now take place at 8:00 a.m. Eastern Daylight Time instead of 8:30 a.m.Participation Instructions for WebcastWhen: Monday, March 27, 2023 at 8:00 AM Eastern Daylight TimeParticipant Registration & Access Link: Click HereAbout Jaguar Health, Napo Pharmaceuticals, Napo Therapeutics & Jaguar Animal HealthJaguar Health, Inc. is a commercial stage pharmaceuticals company focused on developing novel, plant-based, sustainably derived prescription medicines for people and animals with GI distress, including chronic, debilitating diarrhea. Jaguar Health's wholly owned subsidiary, Napo Pharmaceuticals, Inc., focuses on developing and commercializing proprietary plant-based human pharmaceuticals from plants harvested responsibly from rainforest areas. Our crofelemer drug product candidate is the subject of the OnTarget study, an ongoing pivotal Phase 3 clinical trial for prophylaxis of diarrhea in adult cancer patients receiving targeted therapy. Jaguar Health is the majority shareholder of Napo Therapeutics S.p.A. (f/k/a Napo EU S.p.A.), an Italian corporation established by Jaguar Health in Milan, Italy in 2021 that focuses on expanding crofelemer access in Europe. Jaguar Animal Health is a tradename of Jaguar Health.For more information about Jaguar Health, please visit https://jaguar.health. For more information about Napo Pharmaceuticals, visit napopharma.com. For more information about Napo Therapeutics, visit napotherapeutics.com.Forward-Looking StatementsCertain statements in this press release constitute \"forward-looking statements.\" These include statements regarding the expectation that Jaguar Health will hold an investor webcast on March 27, 2023, and the expectation that Jaguar Health will file its Annual Report on March 24, 2023 for the fiscal year ended December 31, 2022. In some cases, you can identify forward-looking statements by terms such as \"may,\" \"will,\" \"should,\" \"expect,\" \"plan,\" \"aim,\" \"anticipate,\" \"could,\" \"...